论文部分内容阅读
目的探讨并观察腹腔内注入华蟾注射液素治疗消化道恶性肿瘤引起的癌性腹水的疗效及不良反应。方法对36例胃肠道晚期癌症患者,经B超和CT诊断为中等至大量腹水,予以腹腔内注入华蟾素80～100ml。每周1次,三四次为1个疗程。结果治疗总有效率(CR+PR)77.8%,且不良反应轻。结论腹腔内注入华蟾素注射液治疗消化道恶性肿瘤引起的癌性腹水疗效显著,不良反应轻,是晚期恶性肿瘤姑息治疗的一种有效方法。
Objective To investigate and observe the efficacy and adverse reactions of intraperitoneal injection of Huadu injection for the treatment of malignant ascites caused by digestive tract malignancies. Methods Thirty-six patients with advanced gastrointestinal cancer were diagnosed as moderate to large amount of ascites by B ultrasound and CT, and were injected cetuxin 80 ~ 100ml intraperitoneally. Once a week, three or four times for a course of treatment. Results The total effective rate (CR + PR) was 77.8% with mild adverse reactions. Conclusion Intraperitoneal injection of cinobufacini injection in the treatment of malignant ascites caused by digestive tract malignancies has obvious curative effect and mild side effects. It is an effective method for palliative treatment of advanced malignant tumors.